Dr. N. Rajesh Kar

Consultant

20 Years of Experience

Radiation Oncologist

MBBS, DMRT, DM, Fellowship

Reg. No.:75602, Tamil Nadu Medical Council

Rela Hospital, Chennai

English, Hindi, Tamil

Consultation Fee ₹ 300

Book an Appointment

About Dr. N. Rajesh Kar

Dr. N. Rajesh Kar is a well-accomplished radiation oncologist with 20 years of expertise in treating cancer patients.
His field of expertise is thyroidectomy, chelation therapy, lumpectomy, external beam radiation for prostate cancer, and hormone therapy for breast cancer.
Dr. Kar is renowned for external beam radiotherapy including 2D technique, three dimensional conformal radiation technique, Intensity Modulated Radiation Technique (IMRT) and Image-Guided Radiation Technique (IGRT).
He specializes in medical oncology, sentinel node biopsy, stereotactic techniques (including SRS, SRT and SBRT), brachytherapy and management of chemotherapy in solid tumors and concurrent chemo-radiation.
He graduated from I.R.T. Perundurai Medical College and Research Centre with an MBBS in 2004 and a DMRT from The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU) in 2009.
He has treated over 5000 cancer patients since starting his practice as an independent consultant.
Dr. N. Rajesh Kar has provided free cancer treatment to over a thousand patients at the private CBCC-Saveetha Dental College in Chennai as part of the Tamil Nadu Chief Minister Scheme.
He provided chemotherapy and radiotherapy treatments even throughout the pandemic and lockdown.
He has authored numerous works in both national and international journals, including the Journal of Clinical and Diagnostic Research and the Indian Journal of Cancer.
Dr. N. Rajesh Kar is a lifetime member of the Association of Radiation Oncologists of India (AROI) and the Tamil Nadu Medical Council.

Book Your Appointment With Dr. N. Rajesh Kar

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS, Perundurai Medical College and Hospital, 2004
DMRT, Madras Medical College and Hospital, 2009
DM in Radiation Oncology, Saveetha University, 2020
Fellowship of the International Council of Ophthalmology (FICO)

Training & Certificates

Palliative Treatment Short Course, 2008

Past Experience

Director, Radiation Oncology, Dr. RAI-CBCC Oncology Centre, 2020
Senior Consultant, Clinical Radiation Oncology, Dr. RAI-CBCC Oncology Centre, 2020
Clinical & Radiation Oncologist, Dr. Rai-CBCC Oncology Centre, Saveetha Dental College Campus, Chennai, 2014
Senior Resident, Apollo Speciality Hospital, Chennai, 2014
Assistant Radiation Oncologist, Billroth Hospital, Chennai, 2010
Medical Officer, Ayesha Hospital, Chennai, 2007

Associations/Membership

Association of Radiation Oncologists of India (AROI)
Tamil Nadu Medical Council (TNMC)

Paper Published

Re-radiotherapy Haemoglobin Level is a Prognosticator in Locally Advanced Head and Neck Cancers Treated with ConcurrentChemoradiation.Narayanaswamy RK, Potharaju M, Vaidhyswaran AN, Perumal K.J Clin Diagn Res. 2015 Jun;9(6):XC14-XC18. DOI: 10.7860/JCDR/2015/11593.6102. Epub 2015 Jun 1. PMID: 26266202.
Poster presentation at UAE Cancer congress 2016 at Dubai, Topic; to compare the DVH doses received with volume to heart and lung (V10-V50) in treating left chest wall post-operative breast carcinoma with 3DCRT Vs Field in Field technique using 6MV LINAC Abstract code:c83z7.
ESMO Asia Singapore 2016 Annals of Oncology Title: Impact of pre-radiotherapy haemoglobin levels on treatment breaks in locally advanced head and neck squamous cell carcinoma poster presentation original submission 376P
ESMO Asia Singapore 2017 Annals of oncology Title: seven fields 3 Dimensional Conformal Radiotherapy technique to spare critical organs in Head and Neck Carcinoma. Poster presentation original submission: #2018
ESMO Asia Singapore 2018 annals of Oncology Title: Radiation dose to contralateral parotid during treatment of carcinoma buccal mucosa: Abstract 387P, Poster presentation original submission
TAT Paris 2018 Annals of Oncology Title: To assess the Pain control and tolerance to drug-induced emesis in Oral and neck carcinoma patients undergoing Chemoradiation treated for pain relief with tapentadol vs tramadol plus paracetamol with and without anti-emetic Support.

Field of Expertise

Adrenal Cancer Treatment
Bacillus Calmette Guerin (BCG) Therapy
Benign and Cancerous Tumor Excision
Bile Duct Cancer Treatment
Bone Marrow Transplant
Brain Tumor Surgery
Breast Biopsy
CAR T-Cell Therapy
Carcinoid Tumor Treatment
Castleman Disease Treatment
Chemotherapy
Colon Cancer Surgery
Completion Thyroidectomy
Endometrial Cancer Treatment
Endoscopic Tumor Removal
Ewing Family of Tumors Treatment
Fine Needle Aspiration
Genitourinary Cancer Treatment
Gestational Trophoblastic Disease (GTD) Treatment
High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer
Hormone Therapy
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Image-Guided Radiation Therapy (IGRT)
Immunotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Kaposi Sarcoma Treatment
Lumpectomy
Malignant Mesothelioma Treatment
Metastatic Tumor Treatment
Minimally Invasive Cancer Surgery
Nasal Cavity and Paranasal Sinus Cancer Treatment
Nasopharyngeal Cancer Treatment
Non-Small Cell Lung Cancer (NSCLC) Treatment
Oncological Surgery
Papillary Thyroid Cancer Treatment
Penile Cancer Treatment
PET CT Scan
Proton Therapy
Radiation Therapy
Radioisotope Therapy
Rhabdomyosarcoma (RMS) Treatment
Robotic Cancer Surgery
Skin Lymphoma Treatment
Small Intestine Cancer Treatment
Targeted Therapy
Thymectomy
Thymoma and Thymic Carcinoma Treatment
Transarterial Chemoembolization (TACE)
Vaginal Cancer Treatment
Vulvar Cancer Treatment
Whipple Procedure
Acute Lymphoblastic Leukemia (ALL)
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia (AML)
Acute Promyelocytic Leukemia (APL)
Adenocarcinoma
Adenosquamous Carcinoma
Adrenocortical Carcinoma
Adult Hodgkins Lymphoma
AIDS-Related Cancer
Ameloblastoma
Anal Cancer
Anaplastic Carcinoma
Appendix Cancer
Atypical Hyperplasia
Atypical Spindle Cell Tumor
Atypical Teratoid/Rhabdoid Tumor (ATRT)
Bacillus Calmette Guerin (BCG) Treatment for Non-Muscle Invasive Bladder Cancer
Basal Cell Carcinoma (BCC)
Basal Cell Carcinoma of the Skin
Benign Bone Tumors
Benign Hematology
Benign Lung Tumors
Benign Soft Tissue Tumors
Bile Duct Cancer, Stones, & Strictures
Bladder Cancer
Blood Cancer
Bone Cancer
Bone Marrow Cancer
Breast Cancer
Breast Cancer During Pregnancy
Breast Cancer Recurrence
Bronchial Tumors
Burkitt Lymphoma
Cancer in Children
Carcinoid Syndrome
Carcinoid Tumor (Gastrointestinal)
Carcinoid Tumors of the Lungs
Cervical Cancer
Childhood Acute Lymphoblastic Leukemia
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia
Chronic Myeloid Leukemia (CML)
Chronic Myeloproliferative Neoplasms
Colorectal Cancer
Cutaneous T-Cell Lymphoma
Cyclic Neutropenia
Desmoid Tumor
Ductal Carcinoma in Situ (DCIS)
Elevated PSA (Prostate-Specific Antigen) Level
Embryonal Tumors
Eosinophilia
Esophageal Cancer
Esophagectomy
Esthesioneuroblastoma
Estrogen Dependent Cancers
Ewing Sarcoma
Extracranial Germ Cell Tumor
Extragonadal Germ Cell Tumor
Extrahepatic Bile Duct Cancer
Fallopian Tube Cancer
Familial Adenomatous Polyposis (FAP)
Familial Adenomatous Polyposis (FAP): Inherited
Follicular Lymphoma
Free Flap Surgery for Treating Osteoradionecrosis
Gallbladder Cancer
Gastric Cancer
Gastrointestinal Stromal Tumor (GIST)
Gestational Trophoblastic Disease
Giant Cell Tumor
Gum Tumor
Hairy Cell Leukemia (HCL)
Head and Neck Cancer
Heart Cancer
Hepatocellular Cancer
Hereditary Non-polyposis Colorectal Cancer (HNPCC)
Hurthle Cell Carcinoma
Hypopharyngeal Cancer
Hypopharyngeal Cancer
Immunotherapy
In-situ Breast Cancer
Incontinence After Prostate Surgery
Inflammatory Breast Cancer
Intensity Modulated Radiation Therapy
Intraocular Melanoma
Invasive Breast Cancer
Invasive Lobular Carcinoma
Islet Cell Tumor
Kaposi Sarcoma
Large Cell Carcinoma
Large Granular Lymphocytic (LGL) leukemia
Leukemia
Lip and Oral Cavity Cancer
Liver Cancer
Liver Cysts & Liver Tumors
Lung Cancer
Lymphatic Cancer
Lymphocytosis
Male Breast Cancer
Malignant Fibrous Histiocytoma (MFH)
Malignant Mesothelioma
Malignant Soft Tissue Tumors
Mediastinal Tumor
Medullary Carcinoma
Melanoma
Merkel Cell Carcinoma
Metastatic Cancer
Metastatic Spinal Tumors
Metastatic Squamous Neck Cancer with Occult Primary
Metastatic Tumors
Mouth Cancer
Multiple Endocrine Neoplasia (MEN) Syndromes
Multiple Myeloma
Myelodysplastic Syndromes
Nasal Cavity and Paranasal Sinus Cancer
Nasopharyngeal Cancer
Neuroendocrine Tumor
Non-Small Cell Lung Cancer
NUT Midline Carcinoma
Oncogenic Osteomalacia
Ophthalmic Cancer
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Ovarian Germ Cell Tumors
Ovarian Primary Peritoneal Cancer
Ovarian Sex Cord Stromal Tumor
Pancreatic Cancer
Pancreatic Neuroendocrine Tumor
Paraganglioma
Paraneoplastic Syndromes
Parathyroid Cancer
Parotid Gland Tumor
Pediatric Chordomas
Pediatric Ependymoma
Pediatric Germ Cell Tumor
Pediatric Rhabdomyosarcoma
Pediatric Spinal Cord Tumor
Pediatric Spinal Tumor
Pediatric Vascular Tumors
Penile Cancer
Pharyngeal Cancer
Pheochromocytoma
Pigmented Villonodular Synovitis (PVNS)
Pineal Region Tumor
Plasma Cell Neoplasms
Pleural Tumor
Pleuropulmonary Blastoma
Prostate Cancer
PTEN Hamartoma Tumor Syndrome (Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome)
Pulmonary Nodules
Pure Red Cell Aplasia (PRCA)
Rectal Cancer
Recurrent Cancer
Relapsed ALL
Relapsed AML
Relapsed Multiple Myeloma
Renal Cell Cancer
Retinoblastoma (Cancer of the Eye)
Retroperitoneal Tumor
Rhabdomyosarcoma
Salivary Gland Cancer
Sarcoma
Sezary Syndrome
Skin Cancer
Skull Base Tumor
Small Cell Carcinoma
Small Cell Lung Cancer
Small Intestine Cancer
Soft Tissue Sarcoma
Spinal Tumor
Squamous Cell Carcinoma (SCC)
Stage 4 Cancer
Stomach Cancer
Sun Exposure & Skin Cancer
Synovial Sarcoma
Testicular Cancer
Throat Cancer
Thrombocytosis
Thymoma and Thymic Carcinoma
Thymus Gland Tumor
Thyroid Cancer
Tracheobronchial Tumor
Transitional Cell Cancer
Urethral Cancer
Uterine Sarcoma
Vaginal Cancer
Vascular Tumor
Vulvar Cancer
Wilms Tumor